Skip to content
Peptide Society Crystagen research vial and carton product photograph

Bioregulators

Crystagen

$69.99

A short-peptide 'bioregulator' from the Russian research tradition of tissue-targeted di-, tri- and tetrapeptides. The exact sequence for this product is not stated; contact us for the ingredient details available for this product.

Available product

One product option is currently available. Final details are confirmed before payment.

Quantity

No payment is collected online. Final details are confirmed before payment.

Product information

Research overview

This product is sold as a short peptide bioregulator. Its exact peptide sequence is not stated on its listing, so we do not describe its identity or research findings beyond its format.

Testing status

Testing documentation for this item has not yet been published. Peptide Society publishes a certificate only when a matching Peptide Society document is available for that product and batch. No purity value, laboratory or verification status is claimed until then.

Testing library

Ordering

Submit an itemized request and a representative will confirm availability, fulfillment and next steps. Requests can be cancelled any time before confirmation.

How ordering works

More in Bioregulators

Bioregulators

Cardiogen

A published review describes Cardiogen as a short peptide associated with cardiovascular research. This product's sequence is not stated; the review does not confirm its contents or effects.

Single option

$69.99

Bioregulators

Cartalax

A published review describes Cartalax as a short peptide associated with cartilage and fibroblast research. This product's sequence is not stated; the review does not confirm its contents or effects.

Single option

$69.99

Bioregulators

Ovagen

A published review describes Ovagen as a short peptide associated with renal-cell and liver-model research. This product's sequence is not stated; the review does not confirm its contents or effects.

Single option

$69.99

Bioregulators

Pancragen

Published research describes Pancragen as a four-amino-acid peptide studied in human pancreatic cell cultures. This product's sequence is not stated, so those cell findings do not confirm its contents or effects.

Single option

$69.99